APPA Pivotal Phase III Study & Results from 2009 ASCO. These results were submitted to the FDA for approval on 3/18/10 of granisetron. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NzM2NXxDaGlsZElEPS0xfFR5cGU9Mw==&t=1 images.investorshub.advfn.com/images/uploads/2010/2/6/vaxxrAPPA_Phase_III_study.JPG images.investorshub.advfn.com/images/uploads/2010/2/6/ypdisAPPA_Phase_III_results.JPG